Diltiazem Hydrochloride Injection
Product Images NDC 0641-6014

The text represents a chemical structure with various compounds including OCH3, COCH3, N, CHoCH2N(CH3)2, and *HCl. It is not possible to determine the exact details of the compound without additional information.*

This is a description of a medication with the product code NDG 0641601301. It is intended for injection and should be stored under refrigeration between 2-8°C (36-46°F). The medication is a sterile solution with a concentration of 25mg per 5mL. The package insert should be consulted to properly administer the medication. It can be given via IV bolus injection or continuous IV infusion. The medication comes in a single-dose vial.*

This is a description of a medication with the NDC code 0641-6013-10. It is a Ditazem Hydrochloride injection with a strength of 25mg per 5mL, intended for direct intravenous injection and continuous intravenous infusion. The medication comes in 10x5 mL single dose vials and must be discarded if not fully used. The vials are nonlatex and sterile. The usual dosage information is available in the package insert. The medication must be stored under refrigeration and not frozen. It may be stored at room temperature for up to one month and needs to be destroyed after that. The medication is manufactured by Hikma, located in Berkeley Heights, NJ.*

This is a description of a medication called Diltiazem HCI Injection. It comes in a single-dose vial of 10ml and contains 50mg per 10ml. It is used for direct IV bolus injection and continuous IV infusion. The suggested dosage is provided in the package insert, and any unused portion should be discarded. It should be stored in refrigeration at 2-8°C (36-46°F). The manufacturer is Hikma based in Berkeley Heights, NJ, and there are also some unidentifiable numbers included in the text.*

This is a description of a medication with the NDC code 0641-6014-10. It is a single-dose vial of HCI Injection with 50mg per 10mL. It is used for direct intravenous bolus injection and continuous intravenous infusion. Each vial contains 5mg Diltiazem Hydrochloride USP, 0.75 mg Citric Acid Anhydrous USP, 0.65 mg Sodium Citrate Dihydrate USP, 50mg Sorbitol NF and Water for Injection USP. It also contains Sodium Hydroxide or Hydrochloric Acid for pH adjustment. The usual dosage should be checked in the package insert. It must be stored under refrigeration between 2 to 8°C (36° to 46°F) and should never be frozen. If stored at room temperature, it should be used within 1 month, and after that must be destroyed. The manufacturer is Hikma, located in Berkeley Heights, NJ 07922 - 462-466-02.*

This is a product description of an injectable medicine with the NDC code 0641-6015-01. It is a 25 mL vial containing 125mg of TR HCI Injection with a concentration of 5mg/mL. The dosage may be administered through direct intravenous bolus or continuous intravenous infusion. The recommended usage details can be found in the package insert. After use, any unused portion should be discarded. The vial is non-latex and sterile, and must be stored between 2 and 8°C. It should not be frozen and can be stored at room temperature for up to a month. After one month at room temperature, the vial should be discarded. The manufacturer of the product is not clear from the text.*

Not available.*

This is a product identification code that contains a Global Trade Item Number (GTIN), a Serial Number (SN), an expiration date (EXP), and a Lot identifier (LOT). The specific information related to the product is not available as it only contains identification codes.*